“No quantitative tool is used to objectively measure if subjects are back in euvolemic state.”

Maltron BioScan touch i8 can assist in volume status assessment in patients with heart  failure. Allowing rapid, accurate, and non-invasive determination of body hydration status. BioScan fluid index can be used to guide fluid-related therapies, achieve optimal hydration status, helping discharge timing and decrease long-term complications. Optimisation of dry weight may also contribute to reduction in the development of worsening renal function (WRF). BioScan touch i8 offers detailed analysis of fluid management and Renal function.

Key Features

Optimise Fluid Management and Diuretic Strategies in Patients with Acute Decompensated Heart Failure

Acute decompensated heart failure patients when admitted into the hospital are often prescribed diuretics. Currently no tool is used to assess when to stop the treatment, besides clinical observations of edema and haemodynamics.

Maltron BioScan touch i8 can help optimise Fluid management in Acutely Decompensated Heart Failure (ADHF), improving clinical outcomes, predicting the occurrence of cardiovascular events and help patient’s discharge. In these patients, monitoring fluid balance adequacy can help clinicians identify high-risk subjects and possibly reduce the incidence of complications.

Worsening renal function during treatment of acute decompensated heart failure (ADHF) often complicates the treatment course of heart failure. It is a strong independent predictor of long-term adverse outcomes.